ClinicalTrials.Veeva

Menu

Telomeres Parameters in Cirrhosis

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Cirrhosis

Study type

Observational

Funder types

Other

Identifiers

NCT02131831
IDO 123 TRX

Details and patient eligibility

About

There are several factors that influence telomere length in patients with cirrhosis, such as metabolic derangements and infectious etiologies, The aim of the study is to compare telomere length and other parameters related to genetic instability in telomere/ telomerase system, in peripheral blood lymphocytes in cirrhosis from different etiologies.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cirrhotic patients from different etiologies

Exclusion criteria

  • decompensated cirrhosis (Child C)
  • age under 18 years
  • any known malignancy, including hepatocellular carcinoma
  • patient that are unable to sign for informed consent

Trial design

50 participants in 1 patient group

cirrhosis

Trial contacts and locations

1

Loading...

Central trial contact

Ido Laish, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems